Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

Author： Boulenger J.P.   Jerabek I.   Cocirc teacute G.   Lavalleacute e Y.J.   Jolicoeur F.B.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 374-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Anxiety

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 59-59

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Anxiety

By  

Current Bioactive Compounds, Vol. 1, Iss. 2, 2005-09 ,pp. : 172-173

Bentham Science Publishers

Access to resources Recommend Favorite

Evidences for the Anti-panic Actions of Cannabidiol

By  

Current Neuropharmacology, Vol. 15, Iss. 2, 2017-01 ,pp. : 291-299

Bentham Science Publishers

Access to resources Recommend Favorite

CCK 4 -induced panic in healthy subjects I: psychological and cardiovascular effects

By Jerabek I.   Boulenger J.-P.   Bradwejn J.   Lavallee Y.-J.   B. Jolicoeur F.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Gastrointestinal Effects of Selective and Non-Selective Non-Steroidal Anti- Inflammatory Drugs

By  

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1779-1793

Bentham Science Publishers

Access to resources Recommend Favorite